Published • loading... • Updated
Novo Nordisk Flags Patient Data Breach From some Clinical Trials in Cyberattack
Novo said the exposed data was pseudonymized and that core business operations remain unaffected while it investigates with external cybersecurity experts.
- On Thursday, Novo Nordisk identified a security incident in which external attackers copied clinical trial patient data from its internal IT systems without authorization, prompting the Danish pharmaceutical company to launch an investigation with external cybersecurity experts.
- Attackers accessed clinical trial data including patient IDs, sex, year of birth, and health information, though Novo Nordisk stated this information is pseudonymized and does not enable any third party to identify participants by name.
- The breach also exposed contact details for HCPs, including registration numbers, email addresses, phone numbers, WhatsApp information, and office locations, prompting Novo Nordisk to warn these individuals about unexpected messages impersonating colleagues.
- Internal systems were taken offline to address the incident, though core business operations remain running as Novo Nordisk works to restore affected systems "in a controlled and safe manner."
- Founded in 1923, Novo Nordisk employs around 67,900 people across 80 offices worldwide and produces GLP-1 receptor agonist drugs Wegovy and Ozempic, which remain unaffected by the incident.
Insights by Ground AI
14 Articles
14 Articles
Novo Nordisk reports cyberattack as UK gives Wegovy pill the nod
Pharmaceutical giant Novo Nordisk says data related to clinical trial participants was stolen as part of a cyberattack. The affected patient data was pseudonymized and not directly linked to names or other direct identifiers, the company said. The maker of the Wegovy weight-loss drug said the affected data types include patient ID, information on trial participation, gender, year of birth, biomarkers, health/immunogenicity data, and lifestyle fa…
Novo Nordisk flags patient data breach from some clinical trials in cyberattack
·New York, United States
Read Full Article
berlingske.dkReposted by 
Kristeligt Dagblad
Kristeligt DagbladAn unnamed party has copied personal data in Novo Nordisk's internal IT systems without permission.
·Copenhagen, Denmark
Read Full ArticleCoverage Details
Total News Sources14
Leaning Left0Leaning Right1Center6Last UpdatedBias Distribution86% Center
Bias Distribution
- 86% of the sources are Center
86% Center
C 86%
14%
Factuality
To view factuality data please Upgrade to Premium
